2,361 Shares in DocuSign, Inc. (NASDAQ:DOCU) Bought by Hudock Inc.

Hudock Inc. purchased a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,361 shares of the company’s stock, valued at approximately $212,000.

Other institutional investors have also bought and sold shares of the company. Modus Advisors LLC bought a new stake in DocuSign during the fourth quarter valued at $36,000. Itau Unibanco Holding S.A. acquired a new position in shares of DocuSign during the third quarter valued at about $28,000. Avion Wealth raised its holdings in shares of DocuSign by 309.2% during the fourth quarter. Avion Wealth now owns 487 shares of the company’s stock valued at $43,000 after purchasing an additional 368 shares during the period. Brooklyn Investment Group acquired a new position in shares of DocuSign during the third quarter valued at about $33,000. Finally, Avior Wealth Management LLC raised its holdings in shares of DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after purchasing an additional 145 shares during the period. Institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,763 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the sale, the chief executive officer now owns 100,062 shares in the company, valued at approximately $8,058,993.48. This trade represents a 7.20 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the completion of the sale, the director now owns 906,430 shares of the company’s stock, valued at approximately $87,959,967.20. This trade represents a 39.08 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 685,773 shares of company stock worth $66,032,726. Insiders own 1.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on DOCU. Citigroup upped their price objective on shares of DocuSign from $87.00 to $113.00 and gave the company a “buy” rating in a report on Friday, December 6th. Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a report on Friday, December 6th. JPMorgan Chase & Co. upped their price objective on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Tuesday, December 3rd. Jefferies Financial Group upped their price objective on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $90.00 price objective (up previously from $57.00) on shares of DocuSign in a report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $92.45.

DocuSign Stock Performance

NASDAQ:DOCU opened at $88.29 on Thursday. The firm has a market cap of $17.84 billion, a price-to-earnings ratio of 18.20, a price-to-earnings-growth ratio of 7.56 and a beta of 0.89. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The firm has a 50-day moving average price of $92.94 and a two-hundred day moving average price of $74.95.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.